Roivant Sciences Investors
Roivant Sciences is a venture capital fund based in New York, New York, founded in 2014 The firm specializes in the development and commercialization of innovative therapies across various therapeutic areas With an investment scale of approximately $611 million, Roivant aims to accelerate the delivery of new medicines to patients in need The organization is committed to leveraging technology and strategic partnerships to enhance the efficiency of drug development processes Roivant Sciences continues to play a significant role in advancing healthcare solutions through its focused investment strategy
Investors
Connections from
Technology:
['BioTech & HealthTech', 'AI Infrastructure', 'Education, Research & SocialTech']
Headquarters:
USA
Last Funding Date:
2023-02-02
Total Funding:
2293000000.0
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
Made Acquisitions
Founded Date:
2014
Investors Number:
15.0
Industry:
FemTech
Employee Number:
501-1000
Estimated Revenue:
$10M to $50M
Investor Type:
Venture Capital Funds
Funding Status:
IPO